2. Materials and Methods
This technique describes the steps involved in carrying out a study to assess how well a physical activity intervention improves cardiovascular health in older people. The purpose of the study is to find out how a regimented exercise programmed affects important cardiovascular metrics including heart rate, blood pressure, and aerobic capacity. Pre- and post-intervention assessments are a part of the randomized controlled trial (RCT) in this study, which complies with ethical guidelines to protect participants' health and safety. A randomized controlled trial (RCT) design will be employed in this study to assess how the physical activity intervention affects participants' cardiovascular health who are elderly. Participants will be randomly assigned to either the intervention group, which will receive the structured exercise programmed, or the control group, which will carry on as normal with no changes to their daily routine. The randomization process will be carried out using a computer-generated random sequence. A pre-intervention and post-intervention measuring design will be used for this study, with baseline measures being acquired prior to the intervention and post-intervention measurements being gathered at the conclusion of the investigation. The control group will not get any additional interventions and will continue with their regular daily routines during the study period.
Changes in heart rate (HR), diastolic blood pressure (DBP), and systolic blood pressure (SBP) from the start of the 12-week intervention to its conclusion are the main outcome measures. Standardized blood pressure cuffs and heart rate monitors will be used to measure these parameters. A 6-minute walk test (6MWT) will be used to evaluate changes in aerobic capacity as a secondary outcome measure. On a pre-marked track, participants will be told to walk as far as they can in six minutes, and the total distance travelled will be noted.
2.1.1. Inclusion Criteria
Individuals who fulfilled the stated diagnostic standards, based on clinical signs and imaging analysis Only one single responsible vertebra is involved; Bone density T value < − 2.5 on dual energy X-ray absorptiometry (DXA), which is in accordance with the diagnostic criteria for osteoporosis.
Before being admitted, every patient had conservative care for a minimum of three months. Prior to making a decision, the patients were furnished with information regarding the benefits and drawbacks of both PVP and PKP. In the interim, they were told that there wasn't enough evidence in medicine to determine which was superior.
1) Vertebral compression fractures caused by osteoporosis: Based on clinical assessment, radiographic evidence (such as X-rays), and the presence of characteristic symptoms (e.g., acute onset of back pain, localized tenderness, or limited spinal mobility), participants had to have a confirmed diagnosis of OVCFs.
2) Gender and age: Participants in the study belonged to a particular age range; in general, older persons 50 years of age or older were the focus of the study because OVCFs are more common in this demographic. Although postmenopausal women account for the majority of OVCFs, both male and female participants were taken into consideration.
3) Consent: In order to participate in the study, participants had to give informed consent, confirming that they were aware of the methods, goals, possible dangers, and advantages of the study.
2.1.2. Exclusion Criteria
1) Those suffering from pathological vertebral fractures, severe internal illnesses, such as spinal metastatic tumors, and tuberculosis in the vertebrae. Individuals who are unable to endure surgery because to significant liver, renal, or cardiovascular malfunction. Individuals whose clinical information is lacking.
2) Severe comorbidities: Individuals who had severe comorbidities that might have a major effect on the results of the study or their capacity to undergo PVP were not allowed to participate. Severe cardiac disorders, cancers, uncontrolled diabetes, or ongoing infections are examples of these comorbidities.
3) Non-osteoporotic fractures: To maintain the study population's homogeneity, individuals with spinal compression fractures brought on by conditions other than osteoporosis, such as trauma, cancer, or infection, were not allowed to participate.
4) Allergy or contraindications: Participants who had a history of allergies to any of the chemicals used in PVP, including local an aesthetics or polymethylmethacrylate, were not allowed to participate. Additionally disqualified were patients who had ongoing bleeding problems or significant coagulopathy, which are contraindications to PVP.
5) Cognitive impairment: To guarantee correct reporting of results and adherence to the study protocol, participants with significant cognitive impairment or those who were unable to give informed consent were excluded.
52 OVCF’s patients without neurologic impairments who had PVP or PKP between January 2020 and December 2020 were enrolled in the study.
2.3. Sample Size Determination and Baseline Data
To maintain statistical power and reduce the possibility of type I and type II errors, the right sample size must be determined. The estimated rate of OVCFs, power (1-β), effect size, predicted dropouts, and desired level of significance (α) were all taken into account while calculating the sample size for the prospective cohort trial.
Previous research on PVP and OVCFs that reported on the effect size and variability in outcome measures like pain intensity or functional status were taken into account when calculating the sample size. The necessary sample size was estimated using statistical software or sample size calculators based on these criteria, with the goal of achieving enough power to identify differences in outcomes that are clinically significant.
In order to examine the clinical outcomes of percutaneous vertebroplasty (PVP) in treating osteoporosis-induced vertebral compression fractures (OVCFs), baseline data collection is an essential first step in a prospective cohort study. Based on baseline evaluations of pain severity, functional status, and quality of life, baseline data offers an overview of the characteristics and medical history of the participants (Litin et al., 2023). The background information gathered in these regions will be explained in this section.
2.4. Demographic Information and Medical History
To describe the study population, demographic information is gathered, such as age, gender, ethnicity, and socioeconomic status. This data aids in determining potential confounding variables and evaluating the generalizability of study findings.
To find pre-existing conditions, comorbidities, and risk factors that could affect the study's results, participants' medical histories are documented. This covers the severity and length of osteoporosis, any previous OVCF history, the existence of chronic illnesses, the use of medications, and the status of smoking.
2.5. Baseline Measurements and Pain Intensity
To evaluate the individuals' starting condition with regard to pain severity, functional state, and quality of life, baseline data are collected.
The Visual Analogue Scale (VAS) and the Numerical Rating Scale (NRS) are two approved measurement instruments that are used to assess pain severity. With higher ratings denoting greater pain severity, participants rate their pain on a scale from 0 to 10.
Standardized questionnaires such as the Roland-Morris Disability Questionnaire (RMDQ) and Oswestry Disability Index (ODI) are used to evaluate functional status. These instruments assess how OVCFs affect participants' capacity to carry out regular tasks.
Assessing participants' general well-being and health-related quality of life is possible through baseline quality of life assessments. A variety of physical and mental health dimensions are evaluated by questionnaires like the Short-Form 36 Health Survey (SF-36).
Researchers set a benchmark for assessing how pain intensity, functional status, and quality of life had changed after the PVP intervention by gathering baseline data. Knowing the features of the study population and pinpointing potential influencing elements for the results is made easier with the use of baseline data.
2.8. Surgical Procedures and Conduct
2.8.1. Surgical Information
Patients in the PKP group underwent general anaesthesia while being operated on in a prone, lordotic posture to preserve posterior extension of the spine. Please refer to our previously published article for information on the conventional technique for PKP surgery. To put it briefly, bilateral balloons were inserted under the endplate via the working tunnel following bilateral transpedicular puncture and cleaning. After gently inflating the balloons to raise the deformed vertebra to its normal height, the superior endplate was elevated and the balloons were deflated. Polymethyl methacrylate cement was utilized to fill the pre-formed cavity once the balloon was taken out. Using C-arm fluoroscopy, the entire process was observed. Most of the stages are similar for PVP groups, however they don't include the balloon. Direct insertion of polymethylmethacrylate bone cement into the vertebra occurred following the creation of a working tunnel.
2.8.2. Clinical and Radiologic Assessment
The visual analogue scale (VAS score 0–10; 0 no pain at all; 10 the worst imaginable) system was employed to evaluate back pain control. Impact on the patient’s daily life was assessed using the Oswestry Disability Index (ODI) questionnaire
[11] | Chen, M., C. Yang, Z. Cai, et al., 2022. Lumbar posterior group muscle degeneration: Influencing factors of adjacent vertebral body re-fracture after percutaneous vertebroplasty. Frontiers in medicine. 9, 1078403. https://doi.org/10.3389/fmed.2022.1078403 |
[12] | Hackbarth, C. B., T. J. Vogl, N. Naguib, et al., 2021. Long-term evaluation of pain reduction after vertebroplasty and kyphoplasty. Acta radiologica open. 10, 20584601211028994. https://doi.org/10.1177/20584601211028994 |
[11, 12]
. Radiographs were taken to measure the rate of cement leakages and refracture, the anterior, middle and posterior vertebral heights, Cobb’s angle and Vertebral wedge ratio
[11] | Chen, M., C. Yang, Z. Cai, et al., 2022. Lumbar posterior group muscle degeneration: Influencing factors of adjacent vertebral body re-fracture after percutaneous vertebroplasty. Frontiers in medicine. 9, 1078403. https://doi.org/10.3389/fmed.2022.1078403 |
[11]
of the fractured vertebral body before and after surgery. The operation time, amounts of cement injected, time of hospital stay and intraoperative blood loss of the two procedures were recorded. All radiographic measurements were performed in a double-blinded fashion by 2 orthopedic surgeons.
In the prospective cohort study investigating the clinical outcomes of percutaneous vertebroplasty (PVP) in the treatment of osteoporosis-induced vertebral compression fractures (OVCFs), standardized surgical procedures were employed to ensure consistency and reproducibility across participants. This section will describe the surgical procedures of PVP and how they were conducted.
Percutaneous vertebroplasty is a minimally invasive procedure that involves the injection of bone cement into the fractured vertebral body to provide stabilization and pain relief. The surgical procedure generally follows a similar procedure:
a) Preoperative Preparation: Before the surgery, patients are assessed to ensure they meet the eligibility criteria. Preoperative evaluations may include medical history review, physical examination, laboratory tests, and radiographic imaging to confirm the diagnosis of OVCFs and assess the vertebral fracture characteristics.
b) Anesthesia: PVP is usually performed under local anesthesia and conscious sedation, although general anesthesia can be considered in specific cases. The anesthesia approach is determined based on the patient's medical condition, surgeon's preference, and patient comfort.
c) Patient Positioning: The patient is positioned prone (lying face down) on the operating table to provide optimal access to the vertebral column. Padding and positioning aids are used to maintain patient comfort and prevent pressure injuries.
d) Fluoroscopic Guidance: Precise catheter placement and cement injection depend on fluoroscopic guidance. During the process, the vertebral column is seen using a fluoroscope, a real-time X-ray imaging tool. It enables the surgeon to determine which vertebra is being targeted, track the path of the needle, and verify the dispersion of cement.
e) Fluoroscopic Guidance: Fluoroscopic guidance is essential for accurate needle placement and cement injection. A fluoroscope, a real-time X-ray imaging device, is used to visualize the vertebral column during the procedure. It allows the surgeon to identify the targeted vertebra, monitor the needle trajectory, and confirm the cement distribution.
f) Needle Insertion: Needle Insertion: The skin is lightly incised in the vicinity of the desired spinal level. Through the pedicle, a biopsy needle or trocar is inserted into the broken vertebral body under the supervision of fluoroscopic imaging. To guarantee precise insertion into the spinal body, the needle's trajectory and depth are closely observed.
g) Cement Injection: After the needle is positioned correctly, the broken vertebral body is injected with bone cement, which is often polymethylmethacrylate. To improve visibility during fluoroscopy, radiopaque material is usually incorporated with the cement. In order to get the best possible cement distribution inside the cracked area, the injection is done slowly.
h) Postoperative Care: The needle is taken out and a tiny bandage is placed over the incision site following the cement injection. Before being released from the recovery room, patients are usually observed. Following surgery, patients may need pain control, assistance with their mobility, and close observation for any untoward complications or unpleasant occurrences.
Adherence to a standard operating procedure aid in maintaining uniformity and reducing participant deviations during the surgery. As a result, it is possible to compare clinical outcomes with accuracy, increasing the study's validity and dependability.
According to Pettersen and Tort (2019), preoperative planning, anesthetic administration, patient positioning, fluoroscopic guidance, needle insertion, cement injection, and postoperative care are all part of the surgical processes involved in percutaneous vertebroplasty. To preserve uniformity and repeatability, these processes are carried out utilizing a defined methodology. Investigators can assess PVP's clinical results in a methodical and trustworthy way by according to a defined methodology.
Data was analysis by Microsoft excel 2020. Figure was prepared by Microsoft excel 2020 and graph Pad prism 8 software.
3. Results
In 2020, 1.92% of women in other professions and 1.92% of women working as clerks suffered from spinal fractures, according to
Figure 1A, which analyses spinal fractures in men and women.
Figure 1B shows that in 2020, 3.84% of women and 0% of men had spinal fractures.
Figure 1. Displayed the percentage of spinal fractures among men and women in 2020 by employment.
Figure 2A displayed a variety of professions, including man's various professions. 2020 saw 3.84% of people, clerks 1.92%, retirees 1.92%, and women 1.92% suffer thoracic vertebral fractures. Technical and professional staff (1.92%), retirees (13.46%), workers (1.92%), clerks (1.92%), other (3.84%), and jobless In 2020, 1.92% of the population experienced a thoracic vertebral fracture. The percentage of thoracic vertebrae fractures in men and women in 2020 was shown in
Figure 2B. In 2020, a quarter of women and a quarter of men suffered from thoracic vertebral fractures, respectively, according to
Figure 1B.
Figure 2. Demonstrated the fracture of thoracic vertebrae occupation and percentage between man and woman in the year of 2020.
The thoracic spine compression fracture that affected 3.84% of other men, 1.92% of retiree men, 11.76% of clerk women, 3.84% of retiree women, and 5.76% of other women in 2020 was noted in
Figure 3A. According to
Figure 3B, 21.15% of women and 5.76% of men experienced thoracic spine compression fractures in 2020.
Figure 3. Demonstrated the compression fracture of thoracic spine occupations and percentage between man and woman in the year of 2020.
Figure 4. In 2020, the percentage of lumbar spinal compression fractures by occupation and the percentage of lumbar fractures by occupation were displayed.
In 2020,
Figure 4A shows that 11.53% of women and 5.76% of men suffered from lumber vertebral compression fractures. A number of professions suffered lumbar vertebral compression fractures in 2020, as shown in
Figure 4B (3.4% retire man, 1.92% clerk man, 5.76% retire woman, 1.92% clerk woman, and 1.92% other profession woman). In 2020, a lumbar fracture injured 5.76% of men and 13.46% of women, according to
Figure 4C.
Figure 4D shows the various occupations in 2020 with the number of people afflicted by lumbar fractures (3,84% retiree women, 3.84% retiree men, 3,84% other profession woman, 3.84% clerk woman, 1.92% other profession man, and 1.92% worker woman).
Figure 5. Man 2020's lumbar spinal compression fracture blood parameters (A-G).
In the year 2020,
Figure 5A illustrated a lumbar vertebral compression fracture of a man. The blood profile revealed no significant changes in blood parameters such as ALT, AST, GGT, ALP, LDH-1, HBDH, CK, and CK-MB within the normal blood range, but there were significant changes in potential blood parameters such as LDH being higher than normal.
Figure 5B shows that in the year 2020, a man suffered a lumbar vertebral compression fracture. The blood profile showed that there were no significant changes in blood parameters within the normal blood range, such as TBA, TBIL, UA, or IBIL, and that there were significant changes in potential blood parameters, such as HCY and CREA, which were higher than normal. The blood profile of a man with a lumbar spinal compression fracture in 2020, as shown in
Figure 5C, indicates that there have been no notable changes in any relevant blood parameters, such as AGP or SA, within the normal blood range. The blood profile of a man with a lumbar spinal compression fracture in 2020, as shown in
Figure 5D, indicated that there were no significant changes in any prospective blood parameters, such as TP, ALB, GLB, APO-A1, or APO-B, within the normal blood range. The blood profile of a man with a lumbar spinal compression fracture in 2020 is shown in
Figure 5E. It shows that there are substantial changes in possible blood parameters, such as APO-E being greater than normal blood range, but no significant changes in LP(α), PA, or RBP. The blood range for CYS-C is normal. As seen in
Figure 5F, which shows a man's blood profile following a lumbar vertebral compression fracture in 2020, there are no significant blood changes (AFU, AMY, GLDH, and ADA falling within the normal blood range) and significant blood changes in the potential blood parameters (LIP is higher than normal blood range). A man's blood profile following a lumbar spinal compression fracture in 2020 is depicted in
Figure 5G. It indicates that there have been no notable changes to any relevant blood parameters, such as IMA or SOD, which are within normal range.
Figure 6. Man 2020 with a lumbar spinal compression fracture and blood parameters.
The blood profile of a man with a lumbar spinal compression fracture in 2020, as shown in
Figure 6, revealed no significant changes in any potential blood parameters, including TG, CHOL, HDL-C, LDL-C, NEFA, SDLDL, β-BH, P, UREA, Na, K, Cl, Ca, and CO
2, all of which were within the normal range.
Figure 7. Man's blood parameters for lumbar fracture in 2020 (A-H).
The blood profile of a man with a lumbar fracture in 2020, as shown in
Figure 7A, showed no significant changes in any potential blood parameters, including ALT, AST, GGT, ALP, LDH, LDH-1, HBDH, CK, and CK-MB, within the normal blood range. In 2020, a lumbar fracture of the man's blood profile (
Figure 7B) revealed no significant alterations in possible blood parameters, such as HCY, TBA, TBIL, DBIL, IBIL, CREA, and UA, which were all within normal range. In 2020, a man suffered a lumbar fracture.
Figure 7C showed that there were notable alterations in the individual's blood profile, including elevated levels of SA and AGP levels above normal. As seen in
Figure 7D, there were no appreciable alterations in blood parameters such as TP, ALB, GLB, APO-A1, and APO-B within the normal blood range following a lumbar fracture in a man in 2020. APO-E and LP are both greater than normal range in the blood profile of a man with a lumbar fracture in 2020, but PA, RBP, and CYS-C are all within normal range.
Figure 7E illustrates these significant changes in the blood profile.
Figure 7F demonstrated that, in 2020, a man's lumbar fracture blood profile indicated no appreciable changes in blood parameters, including AFU, AMY, GLDH, LIP, and ADA, which were all within normal range.
Figure 7G highlights that, in 2020, a man's lumbar fracture blood profile showed no notable alterations, with parameters including IMA and SOD falling within normal range.
Figure 7H illustrates a man's blood profile following a lumbar fracture in 2020; it shows that all parameters, including TG, HDL-C, Na, CL, CO
2, P, and SDLDL, are within normal range. No notable changes were seen. Reference range: 9.0-50.0 IU/L ALT 15.0-40.0 IU/L AST 10.0-60.0 IU/L GGT 40.0-130.0 IU/L ALP 90.0-245.0 IU/L LDH 23.0-72.0 IU/L LDH-1 90.0-250.0 IU/L HBDH 24.0-194.0 IU/L CK 0-25 IU/L CK-MB.
The blood profile of a man who suffered a thoracic vertebrae fracture in 2020 is shown in
Figure 8A. It shows that blood parameters such as GGT, ALP, LDH, and CK-MB were significantly altered and were higher than normal blood range, while blood parameters such as ALT, AST, LDH-1, HBDH, and CK were within normal blood range. APO-A1, APO-B, TP, ALB, and GLB are among the prospective blood parameters that are within the normal blood range, according to
Figure 8B, which describes the blood profile of a thoracic vertebrae fracture in 2020As seen in
Figure 8C, there were no notable changes in any prospective blood parameters, including AFU, GLDH, LIP, AMY, and ADA, within the normal blood range in the year 2020 for thoracic vertebrae fracture man. Blood parameters such as TBA, TBIL, DBIL, and HCY are significantly altered in the 2020 fracture of the thoracic vertebrae man, as
Figure 8D illustrates. In contrast, blood parameters such as IBIL, CREA, and UA are within normal blood range and do not exhibit significant blood changes. The blood profile of the 2020 thoracic vertebrae fracture man, as described in
Figure 8E, revealed no significant changes in any potential blood parameters, including LP(α), PA, RBP, Apo-E, and CYS-C, which are all within the normal blood range.
Figure 8F highlights that, in 2020, a thoracic vertebrae fracture man's blood profile showed no significant changes in prospective blood parameters, such as IMA and SOD, within the normal blood range. The blood profile for the 2020 thoracic vertebrae fracture described in
Figure 8G indicates that there are no noteworthy variations in possible blood parameters, such as SA and AGP, within the normal blood range. In 2020, a thoracic vertebrae fracture man's blood profile was shown in
Figure 8H. It indicated that blood parameters such as CO
2, β-BH, and CHOL, LDL-C, Na, and Cl were all significantly different from normal, and that no blood parameters, such as TG, HDL-C, K, Ca, UREA, P, SDLDL, and NEFA, were significantly different from normal.
Figure 8. Blood parameter of man 2020 fracture of thoracic vertebrae (A-H).
Figure 9. Blood parameter of man 2020 Compression fracture of thoracic spine (A-D).
The blood profile of a man with a thoracic spine compression fracture in 2020 is shown in
Figure 9A, which indicates that there are no notable changes in any relevant blood parameters, such as ALT, AST, GGT, and ALP, within the normal blood range.
Figure 9B, which depicts a compression fracture of the thoracic spine in 2020, indicates that blood parameters such as TBIL, DBIL, CREA, and UA are within normal range and there are no notable changes. The blood profile of a man with a thoracic spine compression fracture in 2020, as shown in
Figure 9C, exhibited no significant alterations in prospective blood parameters, such as TP or ALB, within the normal blood range.
Figure 9D indicates that in 2020, a compression fracture of the thoracic spine in a man, the individual's blood profile revealed no significant changes in possible blood parameters, including Na, K, Cl, CO
2, and UREA, all of which were within the normal range.
Figure 10. Blood parameter of woman 2020 lumbar vertebral compression fracture and Lumbar fracture (A-G).
The blood profile of the 2020 lumbar spinal compression fracture woman described in
Figure 10A indicates that there are no notable variations in possible blood parameters, such as ALT, AST, or GGT, within the normal blood range. The blood profile of a lady with a lumbar spinal compression fracture in 2020, as illustrated in
Figure 10B, revealed no significant changes in any relevant blood parameters, including P, Na, K, Cl, Ca, CO
2, and UREA, all of which were within the normal blood range. The woman with a lumbar spinal compression fracture in 2020, as depicted in
Figure 10C, had a blood profile that indicated no significant changes in possible blood parameters, such as CREA, UA, and TBIL, within the normal range. The blood profile of the 2020 lumbar fracture woman, as shown in
Figure 10D, revealed no significant alterations in prospective blood parameters, such as TP or ALB, within the normal blood range.
Figure 10E highlights that in 2020, a lady who suffered a lumbar fracture showed no significant changes in blood parameters such as TBIL, TBA, CREA, or UA within the normal blood range.
Figure 10F illustrates a lumbar fracture woman's blood profile from the year 2020 and shows that all possible blood parameters, including P, Na, K, Cl, Ca, CO
2, and UREA, are within the normal range and there are no noteworthy changes.
Figure 10G highlights that the blood profile of a 2020 lumbar fracture woman revealed no notable changes in possible blood parameters, such as ALT, AST, or GGT, all falling within the normal blood range.
According to
Figure 11A, a woman with a compression fracture to her thoracic spine in 2020 had blood changes in her blood profile that were not statistically significant. Her blood parameters, such as ALB, were found to be lower than normal. Her blood parameters, such as TP, were found to be within normal range. In the year 2020, a lady with a thoracic spine compression fracture, as depicted in
Figure 11B, her blood parameters showed no notable alterations, with ALT, AST, GGT, and ALP all falling within the normal range. The woman's blood profile from a 2020 compression fracture of the thoracic spine, as shown in
Figure 11C, indicates that there are no notable variations in any relevant blood parameters, including Na, K, Cl, Ca, CO
2, and UREA, within the normal range.
Figure 11D, which describes the woman's blood profile from a compression fracture of the thoracic spine in 2020, showed that prospective blood parameters such CREA, UA, P, and TBIL are all within normal range and have not changed significantly.
Figure 11. Blood parameter of woman 2020 Compression fracture of thoracic spine (A-D).
Figure 12. Blood parameter of women 2020 spinal fracture (A-D).
ALB is lower than normal blood range, and there are no significant changes in potential blood parameters like TP within normal blood range, as shown by
Figure 12A, which depicts the blood profile of a woman who suffered a spinal fracture in 2020. A spinal fracture woman's blood profile in 2020, as shown in
Figure 12B, revealed no appreciable variations in potentially dangerous blood parameters like ALT, AST, or GGT within normal blood range. According to
Figure 12C, a spinal fracture woman's blood profile from 2020 indicated that no significant alterations had been observed in any prospective blood parameters, such as TBIL, CREA, or UA, which were all within the normal blood range.
Figure 12D illustrates a spinal fracture woman's blood profile from 2020 and shows that there are no notable variations in any probable blood parameters, including Na, K, Cl, Ca, CO
2, UREA, and P, within the normal blood range.
Figure 13. Blood parameter of woman 2020 fracture of thoracic vertebrae (A-C).
In 2020, a lady suffered a thoracic vertebrae fracture;
Figure 13A indicated that her blood parameters, including ALT, AST, and GGT, were within normal range and that there were no notable alterations. The woman's blood profile for the 2020 thoracic vertebrae fracture is shown in
Figure 13B. It indicates that there are no significant changes in potential blood parameters such as TP within normal blood range, and that there are significant changes in potential blood parameters such as ALB being lower than normal blood range. In 2020, a lady suffered a thoracic vertebrae fracture;
Figure 13C illustrates that her blood profile, which includes prospective blood parameters including CREA, UA, and TBIL, was within normal range and did not exhibit any noteworthy alterations.
Figure 14. A. 2020 Lumbar vertebral compression, Fracture before surgery, (Female, age 88). B. 2020 Lumbar vertebral compression, Fracture after surgery, (Female, age 88).
Before Surgery,
Figure 14A Conclusion drawn from the analysis: There was the lumbar spine's natural curvature. There were no visible anomalies in the vertebral appendages, and the lumbar 5/ sacral 1 vertebral gap was narrowed. The margins of the lumbar 1–5 vertebrae were sharp.
Comment on imaging: Degenerative alterations of the lumbar region. X-ray in
Figure 14B Following surgery, the examination revealed the following: The lumbar and thoracolumbar vertebrae retained their natural curvatures. There was a thick filling shadow seen inside the flattened thoracic 10 and lumbar 1 vertebra. The lumber 3/4/5, lumbar 5/sacral 1 vertebrae were narrowed, the thoracic 12 vertebrae were somewhat altered into wedges, the thoracolumbar vertebrae's edges were pointed, and certain vertebral appendages were under-clear. There was calcium in the thoracic arch. Imaging comments: Thoracolumbar surgery, kindly perform a clinical self-review; take into account lumbar degenerative degeneration, mild wedging of the thoracic 12 vertebrae, chronic compression, and hardening of the aorta in conjunction with MRI diagnosis.
Figure 15. A. 2020 Lumbar fracture before surgery, Female, age 81. B. 2020 Lumbar fracture after surgery, Female, age 81.
Figure 15A: Preoperative X-ray report Conclusions drawn from the analysis: The lumbar spine had its normal curvature, the lumbar 1 vertebra was wedge-shaped, the rest of the vertebra was undamaged, there was varying degrees of bone hyperplasia at the margins of the lumbar 1–5 vertebrae, there was no discernible narrowing of the vertebral spaces, and there were no discernible anomalies in the vertebral appendages.
Commentary on imaging: 1. Compression fracture of lumbar and vertebral bodies; 2, lumbar spine bone hyperplasia.
After surgery,
Figure 15B shows the X-ray report. Examined findings: There was no discernible narrowing of the vertebral spaces, no obvious abnormalities in the vertebral appendages, the lumbar spine's natural curvature was present, lumbar vertebrae 1 showed a high-density filling shadow, and the rest of the vertebrae were complete in their structure.
Imaging comments: 1. Postoperative lumbar and vertebral body alterations; 2. Hyperplasia of the lumbar spine bones.
X-ray in
Figure 16A Prior to surgery, report: Results of the analysis: More intestines were present, the lumbar spine's transverse process was not clearly visible, the thoracic 12 vertebrae flattened, the lumbar spine had a physiological curvature, the lumbar vertebrae's edges were sharp, and the lumbar 3/4-lumbar 5/ sacrall intervertebral space narrowed.
Imagining remarks: 1. Compression fracture of the 12th thoracic vertebrae; more testing may be required. 2. Degenerative modifications to the lumbar region. X-ray in
Figure 16B Report following surgery: Results of the analysis: More intestinal contents were present, the lumbar spine's transverse process was not clearly visible, the thoracic 12 vertebrae showed a high density of filling shadow, the lumbar spine had a physiological curvature, the lumbar vertebrae's bony edges sharpened, and the vertebral space between lumbar ¾ and lumbar 5/sacral 1 narrowed.
Imagining remarks: 1. Please evaluate the postoperative modifications to the thoracic 12 vertebrae by comparing them clinically to the prior video. 2. Degenerative modifications to the lower back.
Figure 16. A. 2020 fracture of thoracic vertebrae before surgery, Female, age 80. B. 2020 fracture of thoracic vertebrae after surgery, Female, age 80.
Figure 17. A. 2020 fracture of thoracic vertebrae before surgery, Male, age 57. B. 2020 fracture of thoracic vertebrae after surgery, Male, age 57.
Before surgery,
Figure 17A shows the X-ray report: What was seen during the inspection: It was evident that the lumbar vertebrae 7, 9, 12, and 4 had flattened vertebral bodies. and a few of them had wedge-shaped shapes. There was no discernible narrowing of the intervertebral gaps, no visible abnormalities in the vertebral appendages, and a noticeable amount of bone hyperplasia along the borders of the first five lumbar vertebrae.
Commentary on imaging: If additional CT testing was required, compression fractures of the lumbar 4, 9, 12, and thoracic 7 vertebrae were taken into consideration; lumbar vertebral bone hyperplasia.
X-ray report following surgery (
Figure 17B): Examining results revealed: The thoracic vertebrae 4-6 had somewhat flattened bodies, while the thoracic vertebrae 7 and 9 exhibited thick filling shadows on their bodies. The thoracic vertebrae 12 bodies were cuneiform. absence of a noticeable intervertebral narrowing No glaring anomalies were seen in the vertebral appendages, and spaces were seen. In the aortic arch, calcium arcs were seen.
Comments on the image: Clinical self-examination is requested after thoracic vertebrae 7 and 9. The degrees of flattening of thoracic vertebrae 4-6 and 12 were noted, a compression fracture was hypothesised, and more testing was required. the aorta hardening.
Figure 18. A. 2020 spinal fracture after surgery, Male, age 75. B. 2020 spinal fracture before surgery, Male, age 75.
X-ray report following surgery (
Figure 18A). Conclusions drawn from the analysis: There was lumbar physiological curvature, thoracic 11–lumbar 4 vertebrae were cuneiform to varying degrees, the edges of the vertebral bodies became sharp, the lumbar 3 vertebrae appeared discontinuous, and a linear low density shadow was faintly visible. The space between the lumbar vertebrae narrowed, and certain vertebral appendages showed insufficient clarity. The thoracic 12 and lumbar 3 vertebrae showed high density filling shadows.
1. Postoperative thoracic and lumbar spine changes: Please conduct a clinical self-review. 2. Compression fractures were diagnosed as wedge-shaped alterations from thoracolumbar 11 to lumbar 4 vertebrae; suspicious degradation of the lumbar 3 vertebral arch; further testing is advised; 3. Degenerative modifications to the lumbar region.
Before surgery, the spine was examined using X-ray report (
Figure 18B). spinal DR, lumbar anteroposterior Lateral lumbar spine Examined findings: There was lumbar vertebral physiological curvature. The wedge-shapedness of the thoracic-11-lumbo4 vertebrae varied. Some vertebral appendages are unclear, the borders of all ventebral bodies are pomtea, and the lumbar 3 vertebral arch appears discontinuous.
Remarks on the image: Consideration of compression fracture in thoracic 11-lumbar 4 vertebral wedge change; The lumbar arch in lumbar 3 appears to be suspiciously disintegrating, indicating that lumbar bone hyperplasia needs to be further investigated.
Abbreviations
6MWT: 6-Minute Walk Test
LDH: A Lactate Dehydrogenase Test
CK: A Creatine Kinase
CREA: A Creatinine Blood Test
GGT: A Gamma-Glutamyl Transferase
Na: A Sodium Test
TP: A Total Protein
ALP: Alkaline Phosphatase
AFU: Alpha-L-Fucosidase
ALT: Stands for Alanine Transaminase.
ALB: An Albumin Blood Test
HDL-C: An HDL Cholesterol Test
Apo-A1: Apolipoprotein A-I
apob: Apolipoprotein B
APOE: Apolipoprotein E
Ca: Calcium
CO2: Carbon Dioxide
Cl–: Chloride
CHOL: Cholesterol Test
CK-MB: CreatineKinase-Myocardial Band
ΔDBP: Iastolic Blood Pressure
DBIL: Direct Bilirubin
DXA: Dual Energy X Ray Absorptiometry
GLB: GlobulinTest
ΔHR: Heart Rate
Hcy: Homocysteine
HBDH: HydroxybutyrateDehydrogenase
IMA: Ischemia Modified Albumin
KP: Kyphoplasty,
LDH-1: Lactate dehydrogenase-1
LIP: Lipase Test
LP: Lipoprotein(a)
LDL-C: Low-densityLipoprotein Cholesterol Test
MRI: Magnetic Resonance Imaging
ovcfs: Osteoporosis Vertebral Compression Fracture
ODI: Oswestry Disability Index
PVP: Percutaneous Vertebroplasty
PKP: Percutaneous Kyphoplasty
VP: Percutaneous Vertebroplasty
NEFA: Plasma None Sterified Fatty Acid
p: Platelates
K: Potassium
PA: Prealbumin
RCT: Randomized Controlled Trial
RBP: Retinol Binding Protein
RMDQ: Roland-Morris Disability Questionnaire
ADA: Serum Adenosine Deaminase
AMY: Serum Amylase
SA: Serum Amylloid
UREA: Serum Blood Test
CYS-C: Serum CystatinC
SF-36: Short-Form 36 Health Survey
SDLDL: Small Dense Low Density Lipoprotein Cholesterol
Stryker: Spinejack Vertebral Implant (SJ) System
ΔSBP: Systolic Blood Pressure
SOD: The Activity of Superoxide Dismutase
AGP: The Ambulatory Glucose Profile
GLDH: The Glutamate Dehydrogenase
TBA: The Total Bilirubin
AST: The Aspartate Aminotransferase
"TBIL": Total Bilirubin
tbil: Total-Value Bilirubin
TG: Triglycerides Test
UA: Urinalysis, Urine Test
β-BH: Β-blood Hematology Test